Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-21

FDA Approved: LEVETIRACETAM — Supplemental Application (Eugia US LLC)

View source ↗

Summary

FDA approved a supplemental application for the generic levetiracetam product from Eugia US LLC under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)